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Abstract
Background: Cervical cancer is a preventable disease. Unfortunately, its mortality is high in Hungary: 9.2 deaths
/100000 women/year in 2015. The Hungarian organized, nationwide cervical screening program was launched in
2003, but it could improve the coverage rate of cervical cancer screening only by a few percentage points. The vast
majority of women still uses opportunistic screening and the organized screening program had little impact on
participation by women who never or rarely consult their gynecologists. We assessed whether involving general
practitioners in the cervical cancer screening process would increase participation.
Methods: The study consisted of two parts: 1. A questionnaire-based health survey was conducted using a
representative sample of women aged 25 to 65 years from 11 Hungarian counties, in which we studied where
women obtained information about cervical cancer screening. 2. Additionally, a model program and its evaluation
were implemented in the practices of general practitioners in one of the 11 counties (Zala county). In this program,
general practitioners were informed of their patients’ participation in the cervical cancer screening program, and
they motivated those who refused the invitation.
Results: Questionnaire-based health survey: A total of 74% (95% confidence interval (CI): 70–77%) of the target
population had a screening examination within the previous 3 years. The majority (58, 95% CI: 54–62%) of the
target population did not ask for information about cervical cancer screening at all. Only 21% (95% CI: 17–26%)
consulted their general practitioners about cancer screening. Evaluation of the model program: the general
practitioners effectively motivated 24 out of 88 women (27, 95% CI: 18–38%) who initially refused to participate in
the screening program.
Conclusion: The majority of Hungarian women are not informed about cervical cancer screening beyond the
invitation letter. General practitioners could play a more important role in mobilizing the population to utilize
preventive services. The involvement of general practitioners in the organization of the cervical cancer screening
program could increase the participation of those women who generally refuse the services.
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Background
The mortality rate for cervical cancer is very high in
Hungary compared with the average in western Euro-
pean countries (Fig. 1) [1]. More than 400 women die of
this disease each year in a country with a total female
population of 5.28 million [2]. Opportunistic complex
gynecological screening (including colposcopic screen-
ings) and cytological examination with Papanicolaou
smears have a long tradition in Hungary [3]. However,
this tradition has not translated into a decrease in cer-
vical cancer mortality rates. Therefore, national-level
call-and-recall-based organized cervical cancer screening
began in 2003 in Hungary [4]. Women between 25 and
65 years of age are called for a screening every 3 years
by the National Public Health Service [5, 6]. Tradition-
ally, the great majority of eligible women visit their gyne-
cologists, at least within every 3 year, who perform a
complete gynecological examination along with smear-
taking for cytological examination. In this way, a large
number of cervical screening examinations take place
outside organized screening settings [7]. Unfortunately,
the national cervical cancer screening program increased
the proportion of those who received a screening by only
a few percentage points [8, 9]. In 2011 Eurostat reported
that cervical cancer screening participation rate was low
in Hungary. The percentage of women who underwent
at least 1 Pap test in a 3-year period was 35.94%. [10].
Participation in a screening program is known to be
closely related to socioeconomic factors, cultural factors
and attitudes [11, 12]. According to surveys, the majority
of women not attending screenings have low socioeco-
nomic status, and see a gynecologist only if they have
serious complaints. Other reasons are lack of time and
ignorance of the importance of screening [13].
As general practitioners provide health service closest
to the population, they are respected, trustworthy mem-
bers of the local community and can have a key role in
health communication, including mobilization of the
population to participate in screening programs [14].
The aim of the study
The aim of our study was to assess where women obtain
information about cervical cancer screening and to test
whether the involvement of general practitioners in the
cervical cancer screening program process could
increase the participation rate.
Methods
Studies performed
This study was performed within the framework of the
General Practitioners’ Morbidity Sentinel Station Pro-
gram (GPMSSP). The GPMSSP is the first representative
chronic disease morbidity monitoring program in
Hungary [15]. More than 200 general practitioners from
11 counties report the occurrence of non-communicable
diseases with major public health importance via a qual-
ity managed system. In addition to continuous monitor-
ing, the program provides a research framework for
epidemiological and health services research.
This study was conducted in two parts:
1. A questionnaire-based health survey in a represen-
tative group of 25- to 54-year-old women belonging
to the practices of general practitioners participat-
ing in the GPMSSP
2. Screening model program and its evaluation:
involvement of general practitioners in the cervical
cancer screening program process in Zala county.
Fig. 1 Cervical cancer mortality in Hungary and in EU countries from 1990 to 2013. EU-15: countries that joined the European Union before 2004;
EU-13: countries that have joined the European Union since 2004. Source: European Health For All Database. World Health Organization Regional
Office for Europe, Updated January 2016. Standard population: European Old Standard Population
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Participants
Out of the 200 GPs who participated in GPMSSP 96
volunteered to participate in this study. In these prac-
tices 59,730 women aged 25–65 years were registered. In
the first step of selecting the study population we de-
fined the necessary sample size by county on the basis of
the size of the female population aged 25–65 years in
the target population (Baranya, Bács-Kiskun, Borsod-
Abaúj-Zemplén, Győr-Moson-Sopron, Hajdú-Bihar,
Heves, Jász-Nagykun-Szolnok, Komárom-Esztergom,
Nógrád, Szabolcs-Szatmár-Bereg and Zala). In the
second stage we set the necessary sample size for each
general practice taking into account the number of
women aged 25–65 years registered in the GP practices
participating in the GPMSSP. The final size of the ran-
dom sample was 1306 persons. Women living in Zala
county were not included in this process.
In the power calculations of the evaluation of the
model program the minimum detectable success rate
was 20% with ±10% uncertainty. We planned the sample
size in such a way, that if indeed this minimum effect is
achieved then the lower boundary of the 95% confidence
interval of the effect estimate would not include 10%.
We assumed at least 45% participation in the survey,
40% participation rate in the intervention study, 80%
coverage of the cytological test among the participants
of the survey in Zala county who would consent to par-
ticipate in the intervention pilot. This resulted in a ne-
cessary sample size of 1806 in Zala county. To be on the
safe size, 2000 persons were involved in the survey in
Zala county. The sub-sample of the intervention model
program in Zala county was selected from women aged
25–65 years registered at the practices of the GPs par-
ticipating in the model program.
Altogether 3306 women were selected as the final
sample for the program. (Fig. 2.) This oversampling was
taken into account in the analysis of the survey by using
appropriate weights.
Data collection
A questionnaire containing questions regarding demo-
graphic and socioeconomic factors, health status, life-
style (including physical activity, diet, smoking and
sexual activity), knowledge about cervical cancer,
utilization of gynecological services, participation in the
cervical cancer screening program, and the source and
content of information obtained about the screening
program was developed [Additional file 1]. The ques-
tionnaire was tested in focus groups and was further de-
veloped before application in our study. It took
approximately 25 min to complete the questionnaire.
The questionnaires, along with letters containing
instructions, were sent to all participants through their
general practitioners to be answered anonymously.
Participants were asked to send back the questionnaire
by mail. We have previously reported the determinants
of participation in a screening program and the major
causes of refusal [13]. In Zala county, women were add-
itionally asked to provide written consent to participa-
tion in the model program. If they consented, then they
also agreed that their personal data could be used to
contact them, to track their data in the registries of the
cytology labs in the county, and to inform their general
practitioners about their participation in the cervical
cancer screening program.
Intervention model program
We selected all participating women from Zala county
who had not taken part in cervical cancer screening within
3 years prior to the survey but were willing to participate
in the intervention model program (Fig. 2.). Their general
practitioners were informed, and the general practitioners,
in collaboration with the county screening organizing offi-
cer, sent them an invitation to the screening together with
an information leaflet. The women’s participation in the
screening program was monitored by the registries of the
cytological laboratories in the county, which all agreed to
participate in the study.
During the implementation of the screening program
each general practitioner acted according to the study
protocol by following these steps:
– General practitioners sent information letters to
women to be involved in this part of the study with
an invitation to screening and enclosed a leaflet
about some useful information how to prevent
cervical cancer. Each of the 88 women received the
same letter but each information letter was signed
by the respective general practitioner.
– After that, the general practitioners got reports
weekly about who had taken part in the screening
from the coordinator of Zala county, who received
this information from the cytological labs.
– Six weeks after sending the letters, the general
practitioners tried to reach those women who had
not taken part in the screening but at that time in
person or by phone. The general practitioner tried
to motivate and persuade them to cooperate and to
participate in the screening program.
– The participation in screening was observed for a
further 4 weeks based on the reports of the cytological
labs. The screening model program was terminated 4
weeks after the last call or personal invitation.
Statistical analysis
We estimated the frequencies of different characteristics
in the target population by weighting for the age distri-
bution of the counties to correct for refusal. The survey-
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analysis module of the statistical package STATA was
used for the analysis [16].
Results
Survey about obtaining information about the cervical
cancer screening program in the 11 counties
Of the 3306 questionnaires that were sent, 1539 (47%)
were received by the research center. The study partici-
pants were women between the ages of 25 and 65 years
and were 45.6 years old on average (standard deviation
[SD] 11.4). A total of 76% lived with a partner, 21% had
only a primary school education, and 18% had com-
pleted higher education. Table 1 shows the demographic
characteristics of the target population, based on the
weighted analysis (Table 1). Of the target population,
74% (95% confidence interval (CI) 70–77%) had a cyto-
logical examination within the previous 3 years, within
or outside the organized screening program. Only 35.3%
(95% CI: 32.9–37.7) of the 25- to 65-year-old women
from 11 counties were invited to the organized cervical
cancer screening, i.e., only those who did not have an
opportunistic screening test, and only half of those (53.6,
95% CI: 49.4–57.8%) participated. A total of 58% (95%
CI: 54–62%) of the target population did not ask for any
information about cervical cancer screenings. Among
those who asked for information about screenings, the
majority obtained information from a gynecologist (65,
95% CI: 59–71%) and one-third from the media and leaf-
lets provided by the health service. General practitioners
were mentioned as a source of information by only 21%
(95% CI: 17–26%) of women (Table 2). Interested
women primarily asked whether screening was reliable
and capable of detecting early changes (44, 95% CI: 38–
50%) and asked when the screening results would be
available (44, 95% CI: 38–50) (Table 3).
Intervention model program and its evaluation in Zala
county
We selected 88 of the 634 women who had agreed to
take part in the screening model program in Zala county
and who had not participated in a cervical cancer
screening in the previous 3 years. Women who did not
participate in the screening program was older, had
lower incomes and were less educated than women who
participated in it in Zala county. (Table 4.)
Fig. 2 Selection process of the sample for the intervention in Zala County
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As a result of the intervention model program 24 of
the 88 women (27, 95%CI: 18–38%) participated in the
screening program. Of the successful cases, there were
17 occasions in which a letter from the general practi-
tioner was sufficient and 7 instances in which a personal
conversation changed the mind of the participant.
Discussion
Cervical cancer is a preventable cancer; evidence of the
success of cytological screening is indicated by the low
incidence of invasive cervical cancer in well-screened
populations and by the high incidence and mortality in
populations without screening [17]. In 2013, the mortal-
ity rate was 6.02 per 100,000 women in Hungary. Based
on the most recently available data, morbidity rates have
declined over the past decades, with the mortality rate
essentially remaining constant (5–6/100,000 women/
year) since 2005 [1]. Although the organized screenings
began in 2003, the number of sample tests performed
outside the program is still 20 times higher than the
number performed within the screening program [7, 18].
According to our survey, the overall screening rate in
Hungary (74%) is not low. The real frequency, however,
is likely to be lower because of selection bias associated
with a relatively low response rate of 47%. It is reason-
able to assume that, on average, the level of health con-
sciousness was higher among the respondents than that
among the target population [13]. GPs’ frequent contact
with the public and their credibility offer a great poten-
tial for cancer prevention [19]. Effective communication
is a key success factor for an organized screening pro-
gram [20]. Our results showed that the majority of the
target population did not receive any information about
the screening program. Effective communication should
be an inherent part of the screening program in order to
enable the target population to make informed decisions
Table 1 Demographic characteristics of the target population







primary education 21 18–24
secondary education without final examination 21 18–25
secondary education with final examination 30 26–33
post-secondary education without diploma 10 8–13
college or university degree 18 15–21
Table 2 Proportion of women obtaining information about cervical cancer screening from different sources
Proportiona (%) 95% Confidence interval (CI)
Gynecologist 65 59–71
TV, radio 36 30–42
Leaflet found in the consultation-room 30 25–36
Newspaper 24 19–29
Friends, colleagues 24 19–29
Internet 22 17–27
General practitioner 21 17–26
Family members 20 16–25
Specialized textbooks 19 14–24
District nurse 14 10–19
Oncologist 6 4–10
Non-governmental organization 1 0.3–3
Pharmacist 0.5 0.1–1.5
Human papilloma virus outpatient service settings 0.3 0–2
aMore answers were available for selection
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about participation [20–22]. According to the results of
our investigation, women asked for and received relevant
information mainly from their gynecologists and charac-
teristically not before screening but rather in the frame-
work of the gynecological examination.
General practitioners had a very limited role in the
cancer screening program in Hungary. The results ob-
tained from the Zala county model project showed that
the involvement of general practitioners in the cervical
cancer screening program process could increase the
participation of women who generally refuse these ser-
vices. In the model program, a quarter of the women
who typically did not take part in cervical cancer screen-
ing underwent the screening after advice from their gen-
eral practitioner. Some recent developments in the
Hungarian health care system have facilitated the partici-
pation of general practitioners in preventive activities.
General practitioners gained online access to the records
of their patients in the information system of the
National Health Fund, and thus, they could obtain infor-
mation about the type of outpatient and in-patient ser-
vices their patients received, including screenings.
Furthermore, the financing system for general practice,
which still largely depends on capitation, was extended
to performance-based financing [23, 24]. A small pro-
portion of general practice fees currently depend on per-
formance indicators. Participation of the target
population in mammographic screening is already in-
cluded in the list of indicators, but this is not yet the
case for cervical cancer screening.
In developing a screening program, it is important
to increase its accessibility, especially for low-income
families and Romani people [25, 26]. Locally driven
strategies that take into account the sociocultural be-
liefs and values of families can minimize barriers to
cervical cancer prevention and control [27, 28]. If
smears were taken in primary health care settings by
GPs or nurses (as is standard practice in several
Table 3 The type of information women obtained about cervical cancer screening
Answersa mentioned (%) 95% Confidence interval (CI)
Can screening reveal all early changes? 44 38–50
When do I receive the result of the screening? 44 38–50
How often do I have to attend the screening? 35 30–41
What happens if the result is unfavorable? 32 27–37
What does an unfavorable result mean? 28 22–33
How and who will notify me? 27 22–32
Where can I undergo screening? 25 20–30
Where does the screening test take place, and what does the doctor do? 25 20–30
Is screening pain-free? 25 20–30
From which age is screening recommended? 23 19–29
Who performs the screening? 17 13–21
How long does the screening test last? 9 6–12
Is screening risky, and can it cause any damage? 7 4–10
aMore answers were available for selection
Table 4 Socio-demographic characteristics of the study population from Zala county according to participation in cervical screening
within three years
Characteristics Participating in screening (n = 546) Non-participating in screening (n = 88) p-value
Age 43.87 (11.88) 51.44 (11.17) *p<0.001
Household equivalent monthly income (Euro) 442.32 (188.83) 386.82 (170.75) *p = 0.021
Employed 69.9 46.4 **p<0.001
Education **p = 0.006
primary education 8.3 19.8
secondary education without final examination 23.1 24.4
secondary education with final examination 30.3 25.6
post-secondary education without diploma 11.4 14.0
college or university degree 27.0 16.3
Numbers are mean (SD) or percentages. * independent samples t-test; ** chi-square test
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Western European countries [29]), then participation
rates in Hungary would probably increase. Primary
health care services are more accessible to the general
population. Staff are familiar with the cultural and so-
cioeconomic background of the local population and
could also be involved in local communication efforts
regarding the program. It is important that the ser-
vice utilization information is integrated with the
screening information system. This is organized in
Hungary in the framework of the cooperation be-
tween the National Health Insurance Fund and of the
National Public Health Service. The recent develop-
ment of the Hungarian e-health program, especially
the establishment of the National Electronic Health
Records, which centrally stores all medical records of
every patient provides an opportunity for GPs them-
selves to follow-up their patients. To increase the ac-
cessibility of the cervical cancer screening program,
the National Public Health Service has recently
expanded the number of service providers. Health vis-
itors were trained to take the smear and to provide
the service locally, even in small villages. Smear
taking has been integrated into the graduate training
of health visitors, who traditionally provided only ma-
ternal and child care [30].
Pilot Health Visitor’s Cervical Screening Programs
were introduced in 2009, and 15.8% (2009), 11.1% (2010)
and 14.9% (2011) of the invited women appeared in each
year for the request of the health visitors [31]. The
Health Visitor’s Cervical Screening Program was later
institutionalized, and currently it operates as part of the
national public health service. Its effectiveness can fur-
ther be enhanced by the involvement of the GPs in
health communication and motivation of the target
population. Developing a community-based intervention
that is evidence based and theoretically grounded is
challenging and time intensive [32]. It requires collabor-
ation of different professionals, including medical and
health professionals, psychologists, and sociologists.
Limitations of our study were the low response rate in
the survey and the relatively small sample size in the
intervention study. The main strength of our study was
that it resulted in collaboration between primary care,
the public health service and the cytology labs in one
research project which served as a proof of concept to
improve the screening program.
Conclusion
Our results reaffirm that the capacity of primary health
services could be more efficiently utilized in preventive
care in Hungary.
Community-oriented health services need to be reor-
ganized. A new framework of cooperation is needed
from the National Public Health Services, screening
coordinators, general practitioners, nurses, health visi-
tors and patients.
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